| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 15.303 | 36.497 | 42.167 | 42.023 | 41.127 | 13.077 | 37.952 | 59.926 | 49.081 | 53.199 |
| Total Income - EUR | 15.303 | 36.497 | 42.167 | 42.023 | 41.129 | 13.077 | 37.952 | 65.007 | 53.568 | 53.199 |
| Total Expenses - EUR | 17.458 | 35.909 | 51.222 | 46.865 | 47.570 | 22.506 | 32.504 | 45.777 | 45.837 | 46.470 |
| Gross Profit/Loss - EUR | -2.155 | 588 | -9.055 | -4.842 | -6.441 | -9.429 | 5.448 | 19.230 | 7.731 | 6.729 |
| Net Profit/Loss - EUR | -2.614 | -75 | -9.476 | -5.262 | -6.852 | -9.535 | 5.106 | 18.630 | 7.240 | 6.199 |
| Employees | 2 | 2 | 3 | 3 | 2 | 2 | 1 | 2 | 3 | 2 |
Check the financial reports for the company - Medtopstar S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Current Assets | 11.274 | 15.073 | 21.471 | 21.345 | 18.878 | 19.543 | 17.958 | 20.244 | 27.606 | 28.579 |
| Inventories | 11.124 | 14.830 | 20.721 | 20.792 | 17.844 | 18.553 | 16.117 | 18.674 | 19.443 | 23.591 |
| Receivables | 0 | 49 | 106 | 462 | 453 | 673 | 1.181 | 173 | 4.008 | 721 |
| Cash | 150 | 194 | 644 | 92 | 581 | 316 | 661 | 1.396 | 4.154 | 4.266 |
| Shareholders Funds | -2.569 | -2.618 | -12.049 | -17.090 | -23.612 | -32.699 | -26.868 | -8.321 | -2.049 | 4.162 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 13.843 | 17.691 | 33.521 | 38.436 | 42.490 | 52.242 | 44.826 | 28.565 | 29.655 | 24.418 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4712 - 4712" | |||||||||
| CAEN Financial Year |
4719
|
|||||||||
Comments - Medtopstar S.r.l.